×

Growth Reports

Growth Reports
Report Name

Artificial Blood Vessels Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Polymer (Polydioxanone, Elastomer, Polyethylene Terephthalate, Others), By Application (Aortic Disease, Peripheral Artery Disease, Hemodialysis), By End-User (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Specialty Clinics, Others), Countries and Companies Report

Artificial Blood Vessels is projected to register a 5.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024557  |   No. of Pages: 205

Arteriotomy Closure Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Active Closure Devices, Passive Closure Devices), By Application (Femoral Arterial Access Procedures, Radial Arterial Access Procedures), By End-User (Hospitals, Ambulatory Care Centers, Others), Countries and Companies Report

Arteriotomy Closure Devices is projected to register a 6.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024556  |   No. of Pages: 205

Argatroban Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Indication (Buerger's Disease, Arteriosclerosis Obliterans, Heparin-Induced Thrombocytopenia (HIT), Percutaneous Coronary Intervention, Others), By End-User (Hospital Pharmacies, Retail Pharmacies, Others), Countries and Companies Report

Argatroban is projected to register a 3.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024555  |   No. of Pages: 205

Aortic Repair Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Stent Grafts, Catheters), By Procedure (Abdominal Aortic Aneurysm Repair, Open Repair, Endovascular Aneurysm Repair, Thoracic Aortic Aneurysm Repair, Thoracic Endovascular Aneurysm Repair), Countries and Companies Report

Aortic Repair Devices is projected to register a 7.6% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024554  |   No. of Pages: 205

Antithrombin Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Usage (Therapeutics, Diagnostics, Research, Other), By Source (Human, Recombinant Goat Milk, Others), By Type (Anticoagulant, Antiplatelet, Thrombolytic Drugs), By Route of Administration (Oral, Parenteral), Countries and Companies Report

Antithrombin is projected to register a 4.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024552  |   No. of Pages: 205

Antihistamine Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (H1 Antihistamine, H2 Antihistamine, H3 Antihistamine), By Dosage Form (Oral route, Parenteral, Others), By Type (OTC, Prescription-Based), By Disease (Allergic Disorders, Stomach Disorders, Central Nervous System Disorders, Others), Countries and Companies Report

Antihistamine is projected to register a 8.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024551  |   No. of Pages: 205

Anti Viral Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Herpes, Hepatitis, HIV, Influenza, Others), By Distribution Channel (Hospital Pharmacy, Drug Store, Online Pharmacy), Countries and Companies Report

Anti Viral Therapeutics is projected to register a 3.7% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024550  |   No. of Pages: 205

Anti tuberculosis Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Isoniazid, Rifampin, Ethambutol, Pyrazinamide, Fluoroquinolones, Bedaquiline, Amynoglycosides, Thioamides, Cyclic Peptides, Others), By End-User (Hospitals and Clinics, Government Agencies, Non-Profit Organizations, Others), Countries and Companies Report

Anti tuberculosis Therapeutics is projected to register a 6.6% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024549  |   No. of Pages: 205

Anti retroviral Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Protease Inhibitors, Integrase Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Others), Countries and Companies Report

Anti retroviral Drugs is projected to register a 4.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024548  |   No. of Pages: 205